Skip to main content
. 2022 Aug;11(4):530–538. doi: 10.21037/hbsn-20-866

Table 1. Patient characteristics (n=18).

Characteristics Value
Age (years) 63 [53–71]
Male, n (%) 9 (50.0)
BMI (kg/m2) 25.0 [21.6–28.3]
BSA (m2) 1.88 [1.72–1.99]
ASA physical status classification, n (%)
   1 3 (17.0)
   2 7 (39.0)
   3 8 (44.0)
Procedure, n (%)
   Right hemihepatectomy 8 (44.0)
   Extended right hemihepatectomy 5 (28.0)
   Left hemihepatectomy 3 (17.0)
   Segmentectomy ≥3 2 (12.0)
Indication, n (%)
   Colorectal liver metastasis 4 (21.0)
   Hepatocellular carcinoma 1 (6.0)
   Cholangiocarcinoma 11 (61.0)
   Gall bladder carcinoma 1 (6.0)
   Neuro-endocrine tumor 1 (6.0)
Open, n (%) 17 (94.0)
Laparoscopic, n (%) 1 (6.0)
Pre-op TLV (mL) 1,874 [1,289–2,382]
Pre-op FRLV (%) 37.2 [32.5–53.2]
Pre-op TLF (%/min) 14.3 [13.4–16.4]
Pre-op FRLF (%/min) 5.96 [4.69–8.35]

Continuous data are expressed as median and IQR. TLV, total liver volume; FRLV, future remnant liver volume; TLF, total liver function; FRLF, future remnant liver function; IQR, interquartile range.